| __timestamp | Corcept Therapeutics Incorporated | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25669000 | 27632226 |
| Thursday, January 1, 2015 | 48925000 | 97707000 |
| Friday, January 1, 2016 | 79263000 | 129037000 |
| Sunday, January 1, 2017 | 155647000 | 151332000 |
| Monday, January 1, 2018 | 246032000 | 158719000 |
| Tuesday, January 1, 2019 | 300982000 | 170104000 |
| Wednesday, January 1, 2020 | 348292000 | 192195000 |
| Friday, January 1, 2021 | 360697000 | 220706000 |
| Saturday, January 1, 2022 | 396473000 | 204426000 |
| Sunday, January 1, 2023 | 475894000 | 133788000 |
Unleashing the power of data
In the competitive landscape of biotechnology, Corcept Therapeutics Incorporated and Travere Therapeutics, Inc. have showcased intriguing trajectories in gross profit over the past decade. Since 2014, Corcept has demonstrated a remarkable growth, with its gross profit surging by over 1,750%, reaching approximately $476 million in 2023. This growth reflects Corcept's strategic advancements and market positioning.
Conversely, Travere Therapeutics, while also experiencing growth, has seen a more modest increase of around 384% in the same period, peaking at about $221 million in 2021 before a slight decline. This divergence highlights the varying strategies and market responses of these two companies.
As the biotech industry continues to evolve, these insights provide a window into the financial health and strategic directions of Corcept and Travere, offering valuable lessons for investors and industry analysts alike.
Gross Profit Comparison: Johnson & Johnson and Travere Therapeutics, Inc. Trends
AbbVie Inc. and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Merck & Co., Inc. and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: AstraZeneca PLC and Corcept Therapeutics Incorporated Trends
Key Insights on Gross Profit: Zoetis Inc. vs Corcept Therapeutics Incorporated
Key Insights on Gross Profit: Dr. Reddy's Laboratories Limited vs Travere Therapeutics, Inc.
Gross Profit Trends Compared: Exelixis, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Corcept Therapeutics Incorporated vs Veracyte, Inc.
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs MorphoSys AG
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Vericel Corporation
MorphoSys AG vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown